21570450|t|Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.
21570450|a|The novel multifunctional brain permeable iron, chelator M30 [5-(N-methyl-N-propargyaminomethyl)-8-hydroxyquinoline] was shown to possess neuroprotective activities in vitro and in vivo, against several insults applicable to various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. In the present study, we demonstrate that systemic chronic administration of M30 resulted in up-regulation of hypoxia-inducible factor (HIF)-1alpha protein levels in various brain regions (e.g. cortex, striatum, and hippocampus) and spinal cord of adult mice. Real-time RT-PCR revealed that M30 differentially induced HIF-1alpha-dependent target genes, including vascular endothelial growth factor (VEGF), erythropoietin (EPO), enolase-1, transferrin receptor (TfR), heme oxygenase-1 (HO-1), inducible nitric oxide synthase (iNOS), and glucose transporter (GLUT)-1. In addition, mRNA expression levels of the growth factors, brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) and three antioxidant enzymes (catalase, superoxide dismutase (SOD)-1, and glutathione peroxidase (GPx)) were up-regulated by M30 treatment in a brain-region-dependent manner. Signal transduction immunoblotting studies revealed that M30 induced a differential enhanced phosphorylation of protein kinase C (PKC), mitogen-activated protein kinase (MAPK)/ERK kinase (MEK), protein kinase B (PKB/Akt), and glycogen synthase kinase-3beta (GSK-3beta). Together, these results suggest that the multifunctional iron chelator M30 can up-regulate a number of neuroprotective-adaptive mechanisms and pro-survival signaling pathways in the brain that might function as important therapeutic targets for the drug in the context of neurodegenerative disease therapy.
21570450	70	74	iron	Chemical	MESH:D007501
21570450	90	93	M30	Chemical	-
21570450	101	106	mouse	Species	10090
21570450	156	160	iron	Chemical	MESH:D007501
21570450	171	174	M30	Chemical	-
21570450	176	229	5-(N-methyl-N-propargyaminomethyl)-8-hydroxyquinoline	Chemical	-
21570450	347	373	neurodegenerative diseases	Disease	MESH:D019636
21570450	383	402	Alzheimer's disease	Disease	MESH:D000544
21570450	404	423	Parkinson's disease	Disease	MESH:D010300
21570450	429	458	amyotrophic lateral sclerosis	Disease	MESH:D000690
21570450	537	540	M30	Chemical	-
21570450	570	607	hypoxia-inducible factor (HIF)-1alpha	Gene	15251
21570450	714	718	mice	Species	10090
21570450	751	754	M30	Chemical	-
21570450	778	788	HIF-1alpha	Gene	15251
21570450	823	857	vascular endothelial growth factor	Gene	22339
21570450	859	863	VEGF	Gene	22339
21570450	866	880	erythropoietin	Gene	13856
21570450	882	885	EPO	Gene	13856
21570450	899	919	transferrin receptor	Gene	22042
21570450	921	924	TfR	Gene	22042
21570450	927	943	heme oxygenase-1	Gene	15368
21570450	945	949	HO-1	Gene	15368
21570450	952	983	inducible nitric oxide synthase	Gene	18126
21570450	985	989	iNOS	Gene	18126
21570450	996	1024	glucose transporter (GLUT)-1	Gene	20525
21570450	1085	1118	brain-derived neurotrophic factor	Gene	12064
21570450	1120	1124	BDNF	Gene	12064
21570450	1130	1168	glial cell-derived neurotrophic factor	Gene	14573
21570450	1170	1174	GDNF	Gene	14573
21570450	1207	1215	catalase	Gene	12359
21570450	1217	1245	superoxide dismutase (SOD)-1	Gene	20655
21570450	1302	1305	M30	Chemical	-
21570450	1409	1412	M30	Chemical	-
21570450	1540	1543	MEK	Gene	17242
21570450	1564	1567	PKB	Gene	11651
21570450	1568	1571	Akt	Gene	11651
21570450	1578	1608	glycogen synthase kinase-3beta	Gene	56637
21570450	1610	1619	GSK-3beta	Gene	56637
21570450	1679	1683	iron	Chemical	MESH:D007501
21570450	1693	1696	M30	Chemical	-
21570450	1894	1919	neurodegenerative disease	Disease	MESH:D019636
21570450	Association	15251	22339
21570450	Association	15251	22042
21570450	Association	15251	18126
21570450	Association	13856	15251
21570450	Association	15251	20525
21570450	Association	15251	15368

